CLINICAL AND IMMUNOLOGICAL EFFICACY OF THE RECOMBINANT INTERFERON alfa-2b OF ACUTE EPSTEIN-BARR VIRAL MONONUCLEOSIS IN PRESCHOOL CHILDREN

Conducted clinical and immunological examination of 51 children with acute Epstein-Barr viral mononucleosis (EBV) in age from 1 year to 7 years. All children diagnosed with a moderate degree of the disease. In the treatment of 25 people (comparison group) used the standard treatment (pathogenetic, s...

Full description

Saved in:
Bibliographic Details
Main Authors: V. N. Timchenko, S. L. Bannova, N. M. Kalinina, O. V. Bulina, E. N. Vyzhlova, A. N. Nazarova, А. V. Fedorova
Format: Article
Language:Russian
Published: LLC "Diagnostics and Vaccines" 2016-09-01
Series:Детские инфекции (Москва)
Subjects:
Online Access:https://detinf.elpub.ru/jour/article/view/243
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849709249467252736
author V. N. Timchenko
S. L. Bannova
N. M. Kalinina
O. V. Bulina
E. N. Vyzhlova
A. N. Nazarova
А. V. Fedorova
author_facet V. N. Timchenko
S. L. Bannova
N. M. Kalinina
O. V. Bulina
E. N. Vyzhlova
A. N. Nazarova
А. V. Fedorova
author_sort V. N. Timchenko
collection DOAJ
description Conducted clinical and immunological examination of 51 children with acute Epstein-Barr viral mononucleosis (EBV) in age from 1 year to 7 years. All children diagnosed with a moderate degree of the disease. In the treatment of 25 people (comparison group) used the standard treatment (pathogenetic, symptomatic), treatment 26 people (main group) included the use as antiviral and immunotropic means of the preparation of human recombinant interferon Alfa-2b in the form of rectal suppositories — VIFERON®. The immunological survey was conducted in dynamics: at the height of the disease and in the convalescence period. The blood was determined indicators of cellular immunity (leukocytes, lymphocytes, CD3+, CD4+, CD8+, CD56+, HLAII+, CD95+, CD1 6+, CD25+), the concentration of IFN-a, IFN-y, IL-4 levels in spontaneous and induced production, in the serum). At milestones children of the main group noted rapid regression of clinical symptoms, normalization of body temperature, reducing intoxication, positive dynamics lymphoproliferative syndrome), a significant reduction in bed-days, no layering respiratory viral infections. Interferon had also expressed a positive impact on the changed parameters of cellular immunity and cytokine links. At the same time, 80% of patients after basic treatment is established the predominance of Th2 type immune response, indicating a high risk of developing chronic course of EBV-mononucleosis.
format Article
id doaj-art-825b81d0e69640c5bd93b0caffb2d3cc
institution DOAJ
issn 2072-8107
language Russian
publishDate 2016-09-01
publisher LLC "Diagnostics and Vaccines"
record_format Article
series Детские инфекции (Москва)
spelling doaj-art-825b81d0e69640c5bd93b0caffb2d3cc2025-08-20T03:15:22ZrusLLC "Diagnostics and Vaccines"Детские инфекции (Москва)2072-81072016-09-01153303810.22627/2072-8107-2016-15-3-30-38237CLINICAL AND IMMUNOLOGICAL EFFICACY OF THE RECOMBINANT INTERFERON alfa-2b OF ACUTE EPSTEIN-BARR VIRAL MONONUCLEOSIS IN PRESCHOOL CHILDRENV. N. Timchenko0S. L. Bannova1N. M. Kalinina2O. V. Bulina3E. N. Vyzhlova4A. N. Nazarova5А. V. Fedorova6Saint Petersburg State Pediatric Medical University of the Ministry of Halth of the Russian FederationSaint Petersburg State Pediatric Medical University of the Ministry of Halth of the Russian FederationAll-Russian Center of Emergency and Radiation Medicine named A.M. Nikiforov of EMERCOM RussiaSaint Petersburg State Pediatric Medical University of the Ministry of Halth of the Russian FederationResearch Institute of Microbiology and Epidemiology named N.F. Gamalei of the Ministry of Health of the Russian Federation , MoscowSaint Petersburg State Pediatric Medical University of the Ministry of Halth of the Russian FederationSaint Petersburg State Pediatric Medical University of the Ministry of Halth of the Russian FederationConducted clinical and immunological examination of 51 children with acute Epstein-Barr viral mononucleosis (EBV) in age from 1 year to 7 years. All children diagnosed with a moderate degree of the disease. In the treatment of 25 people (comparison group) used the standard treatment (pathogenetic, symptomatic), treatment 26 people (main group) included the use as antiviral and immunotropic means of the preparation of human recombinant interferon Alfa-2b in the form of rectal suppositories — VIFERON®. The immunological survey was conducted in dynamics: at the height of the disease and in the convalescence period. The blood was determined indicators of cellular immunity (leukocytes, lymphocytes, CD3+, CD4+, CD8+, CD56+, HLAII+, CD95+, CD1 6+, CD25+), the concentration of IFN-a, IFN-y, IL-4 levels in spontaneous and induced production, in the serum). At milestones children of the main group noted rapid regression of clinical symptoms, normalization of body temperature, reducing intoxication, positive dynamics lymphoproliferative syndrome), a significant reduction in bed-days, no layering respiratory viral infections. Interferon had also expressed a positive impact on the changed parameters of cellular immunity and cytokine links. At the same time, 80% of patients after basic treatment is established the predominance of Th2 type immune response, indicating a high risk of developing chronic course of EBV-mononucleosis.https://detinf.elpub.ru/jour/article/view/243acute ebv-mononucleosispreschool childrencellular and cytokine links of immunityrecombinant interferon alfa-2bviferon®
spellingShingle V. N. Timchenko
S. L. Bannova
N. M. Kalinina
O. V. Bulina
E. N. Vyzhlova
A. N. Nazarova
А. V. Fedorova
CLINICAL AND IMMUNOLOGICAL EFFICACY OF THE RECOMBINANT INTERFERON alfa-2b OF ACUTE EPSTEIN-BARR VIRAL MONONUCLEOSIS IN PRESCHOOL CHILDREN
Детские инфекции (Москва)
acute ebv-mononucleosis
preschool children
cellular and cytokine links of immunity
recombinant interferon alfa-2b
viferon®
title CLINICAL AND IMMUNOLOGICAL EFFICACY OF THE RECOMBINANT INTERFERON alfa-2b OF ACUTE EPSTEIN-BARR VIRAL MONONUCLEOSIS IN PRESCHOOL CHILDREN
title_full CLINICAL AND IMMUNOLOGICAL EFFICACY OF THE RECOMBINANT INTERFERON alfa-2b OF ACUTE EPSTEIN-BARR VIRAL MONONUCLEOSIS IN PRESCHOOL CHILDREN
title_fullStr CLINICAL AND IMMUNOLOGICAL EFFICACY OF THE RECOMBINANT INTERFERON alfa-2b OF ACUTE EPSTEIN-BARR VIRAL MONONUCLEOSIS IN PRESCHOOL CHILDREN
title_full_unstemmed CLINICAL AND IMMUNOLOGICAL EFFICACY OF THE RECOMBINANT INTERFERON alfa-2b OF ACUTE EPSTEIN-BARR VIRAL MONONUCLEOSIS IN PRESCHOOL CHILDREN
title_short CLINICAL AND IMMUNOLOGICAL EFFICACY OF THE RECOMBINANT INTERFERON alfa-2b OF ACUTE EPSTEIN-BARR VIRAL MONONUCLEOSIS IN PRESCHOOL CHILDREN
title_sort clinical and immunological efficacy of the recombinant interferon alfa 2b of acute epstein barr viral mononucleosis in preschool children
topic acute ebv-mononucleosis
preschool children
cellular and cytokine links of immunity
recombinant interferon alfa-2b
viferon®
url https://detinf.elpub.ru/jour/article/view/243
work_keys_str_mv AT vntimchenko clinicalandimmunologicalefficacyoftherecombinantinterferonalfa2bofacuteepsteinbarrviralmononucleosisinpreschoolchildren
AT slbannova clinicalandimmunologicalefficacyoftherecombinantinterferonalfa2bofacuteepsteinbarrviralmononucleosisinpreschoolchildren
AT nmkalinina clinicalandimmunologicalefficacyoftherecombinantinterferonalfa2bofacuteepsteinbarrviralmononucleosisinpreschoolchildren
AT ovbulina clinicalandimmunologicalefficacyoftherecombinantinterferonalfa2bofacuteepsteinbarrviralmononucleosisinpreschoolchildren
AT envyzhlova clinicalandimmunologicalefficacyoftherecombinantinterferonalfa2bofacuteepsteinbarrviralmononucleosisinpreschoolchildren
AT annazarova clinicalandimmunologicalefficacyoftherecombinantinterferonalfa2bofacuteepsteinbarrviralmononucleosisinpreschoolchildren
AT avfedorova clinicalandimmunologicalefficacyoftherecombinantinterferonalfa2bofacuteepsteinbarrviralmononucleosisinpreschoolchildren